Summary
The expression pattern of VEGF, p53 and ICAM-1 was studied in conjunctiva of diabetic patients with and without retinopathy. All patients underwent a complete ophthalmic examination, including retinal fluorescein angiography. Indirect immunoperoxidase method was performed on 20 eyes of 20 patients with type II diabetes without DR and on 5 eyes of 5 patients with PDR. A control study was performed on 6 normal conjunctiva undertaken during cataract surgery. Immunoreactivity of VEGF, p53 and ICAM-1 was found in epithelial, fibroblast and vascular endothelial cells. For the same duration of diabetes, a strong to moderate or weak immunoreactivity was observed in the conjunctiva of patients without retinopathy. In patients with PDR, the expression was strong for all these proteins. The immunoreactivity was correlated between VEGF, p53 and ICAM-1. In the normal conjunctiva, a weak to negative immunostaining was observed. The presence of these proteins in the conjunctiva of diabetic patients without retinopathy may add new data in the pathogenesis of diabetic retinopathy. Further studies are needed to confirm this hypothesis.
Similar content being viewed by others
References
Adamis AP (2002) Is diabetic retinopathy an inflammatory disease. Br J Ophthalmol 86:363–365
Aiello LP (1997) Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 8:19–31
Aiello LP (1997) Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications of therapies. Ophthalmic Res 29:354–362
Antcliff RJ, Marshall J (1999) The pathogenesis of edema in diabetic maculopathy. Seminars in Ophthalmology 14:223–232
Archer DB (1999) Diabetic retinopathy.: some cellular, molecular and therapeutic considerations. Eye 13:497–523
Bargonetti J, Manfredi JJ (2002) Multiple roles of the tumor suppressor p53. Curr Opin Oncol 14:86–91
Barile GR, Chang SS, Park LS, Reppucci VS, Schiff WM, Schmidt AM (1999) Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy. Curr Eye Res 19:219–227
Boulton M, Foreman D, Williams G, McLeod D (1998) VEGF localization in diabetic retinopathy. Br J Ophthalmol 82:561–568
Casey R, Li WW (1997) Factors controlling angiogenesis. Am J Ophthalmol 124:521–529
Chakrabarti S, Cukiernik M, Hileeto D, Evans T, Chen S (2000) Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16:393–407
Cheung AT, Price AR, Duong PL, Ramanujam S, Gut J, Larkin EC, Chen PC, Wilson DM (2002) Microvascular abnormalities in pediatric diabetic patients. Microvasc Res 63:252–258
Chowers I, Folberg R, Livni N, Pe’er J (2002) p53 immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroids. Curr Eye Res 24:105–108
Ciulla TA, Harris A, Latkany P, Piper HC, Arend O, Garzozi H, Martin B (2002) Ocular perfusion abnormalities in diabetes. Acta Ophthalmol Scand 80:468–477
Esser P, Bresgen M, Fischbach R, Heimann K, wiedmann P (1995) Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders. Ger J Ophthalmol 4:269–274
Gupta MK, Qin RY (2003) Mechanism and its regulation of tumor induced angiogenesis. Word J Gastroenterol 9:1144–1145
Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Döhmen S, Adamis AP (2002a) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-A suppression. The FASEB Journal express article 10.1096/fj.01–0707fje. Publishes online January 30
Joussen AM., Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP (2002) Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leucocyte adhesion in vivo. Am J Pathol 160:501–509
Kim I, Ryan AM, Rohan R, Amano S, Agular S, Miller JW, Adamis AP (1999) Constitutive expression of VEGF, VEGFR-1, VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci 40: 2115–2121
Larkins RG, Dunlop ME and Johnson EIM (1996) The pathogenesis of diabetic retinopathy. Aust NZ J Ophthalmol 24:97–104
Lee Do-H, Cho HJ, Kim JT, Choi JS, Joo CK (2001) Expression of vascular endothelial growth and inducible nitric oxide synthetase in pterygia. Cornea 20:738–742
Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH (1999) Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 40:2453–2457
Lu M, Adamis AP (2002) Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. Ophthalmol Clin N Am 15:69–79
Lutty GA, McLeod DS, Merges C, Diggs M, Plouet J (1996) Localization of vascular endothelial growth factor in human retina and choroïd. Arch Ophthalmol 114:971–977
Marcovich AL, Morad Y, Sandbank J, Huszar M, Rosner M, Pollack A, Herbert M, Dayan YB (2002) Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res 25:17–22
McLeod DS, Lefer DJ, Merges C, Lutty GA (1995) Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147:642–653
Mineta H, Miura K, Ogino T, Takebayashi S? Misawa K, Ueda Y (2002) Vascular endotheluial growth factor (VEGF) expression correlates with p53 and Ki-67 expressions in tongue squamous cell carcinoma. Anticancer Res 22:1039–1044
Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP (2000) Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156:1733–1739
Moromizato Y, Stechschulte S, Miyamoto K, Murata T, Tsujikawa A, Joussen AM, Adamis AP (2000) CD18 and ICAM-1 dependent corneal neovascularization and inflammation after limbal injury. Am J Pathol 157:1277–1281
Nicoletti VG, Nicoletti R, Ferrara N, Meli G, Reibaldi M, Reibaldi A (2003) Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor. Exp Clin Endocrinol Diabetes 111:209–214
Noma H, Funatsu H, Yamashita H, Kitano S, Mishima HK, Hori S (2002) Regulation of angiogenesis in diabetic retinopathy. Arch Ophthalmol 120:1075–1080
Paques M, Massin P and Gaudric A (1997) Growth factors and diabetic retinopathy. Diabetes Metabol 23:125–130
Quart E (2001) VEGF and tumor angiogenesis. J Biol Med 18:59–66
Rosa AR, Schirmer CC, Gurski RR, Meurer L, Edelweiss MI, Kruel CD (2003) Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the oesophagus. Dis Esophagus 16:112–118
Sangwan VS, Merchant A, De la Maza MS, Foster S (1998) Leucocyte adhesion molecule expression in scleritis. Arch Ophthalmol 116:1476–1480
Sarioglu S, Sokmen S, Terzi C, Ozer E, Fuzun M, Kupelioglu A (2001) Relationship of angiogenesis and p53 protein expression in colorectal carcinomas. Colorectal Dis 3:38–41
Segawa Y, Shirao Y, Yamagishi S, Higashide T, Kobayashi M, Katsuno K, Iyobe A, Harada H, Sato F, Miyata H, Asai H, Nishimura A, Takahira M, Souno T, Segawa Y, Maeda K, Shima K, Mizuno A, Yamamoto H, Kawasaki K (1998) Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy. Ophthalmic Res 30:333–339
Sone H, Kawakami Y, Okuda Y, Sekine Y, Honmura S, Matsuo K, Segawa T, Suzuki H, Yamashita K (1997) Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologica 40:726–730
Vorkauf M, Duncker G, Nölle B, Sterry W (1993) Adhesion molecules in normal human conjunctiva. An immunohistological study using monoclonal antibodies. Graefes Arch Clin Exp Ophthalmol 231:323–330
Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T and Argov S (2002) Overexpression of p53 tumor suppressor gene in pterygia. Eye 16:619–621
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kria, L., Khalfaoui, T., Mkannez, G. et al. Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients. J Mol Hist 36, 381–390 (2005). https://doi.org/10.1007/s10735-005-9002-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-005-9002-9